R-(-)-Deprenyl hydrochloride, powder, >=98% (HPLC)

Code: M003-250MG D2-231

Biochem/physiol Actions

Selective MAO-B inhibitor; anti-Parkinsonian agent.

Features and Benefits

This compound is featured on the Dopamine and N...


 Read more

Your Price
€97.20 250MG
€119.56 inc. VAT
REQUEST

Biochem/physiol Actions

Selective MAO-B inhibitor; anti-Parkinsonian agent.

Features and Benefits

This compound is featured on the Dopamine and Norepinephrine Metabolism and Histamine Synthesis and Metabolism pages of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

This compound was developed by Sanofi Aventis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Packaging

1 g in poly bottle

250 mg in poly bottle

assay≥98% (HPLC)
colorwhite
formpowder
Gene Informationhuman ... MAOB(4129)
InChI keyIYETZZCWLLUHIJ-UTONKHPSSA-N
InChI1S/C13H17N.ClH/c1-4-10-14(3)12(2)11-13-8-6-5-7-9-13;/h1,5-9,12H,10-11H2,2-3H3;1H/t12-;/m1./s1
mp141-142 °C
optical activity[α]25/D −10.8°, c = 6.48 in H2O(lit.)
originatorSanofi Aventis
Quality Level100
SMILES stringCl[H].C[C@H](Cc1ccccc1)N(C)CC#C
solubilityH2O: >10 mg/mL
Cas Number14611-52-0
This product has met the following criteria to qualify for the following awards:



PROCEED TO CHECKOUT

HAVE AN ACCOUNT? LOGIN
GUEST CHECKOUT

Proceed as a guest. You will have the option to register to access exclusive pricing and stock availability features after checkout.